Publicacions en col·laboració amb investigadors/es de Hospital de la Santa Creu i Sant Pau (10)

2020

  1. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology

    Translational Research, Vol. 215, pp. 86-101

  2. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

2018

  1. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481

  2. Non-coding RNAs and exercise: Pathophysiological role and clinical application in the cardiovascular system

    Clinical Science, Vol. 132, Núm. 9, pp. 925-942

  3. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy

    Journal of Molecular Medicine, Vol. 96, Núm. 8, pp. 845-856

2017

  1. Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers

    International Journal of Cardiology, Vol. 228, pp. 870-880

2016

  1. Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes

    Scientific Reports, Vol. 6

  2. Genetic basis of dilated cardiomyopathy

    International Journal of Cardiology, Vol. 224, pp. 461-472

2010

  1. A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study

    Atherosclerosis, Vol. 212, Núm. 2, pp. 636-643

2008

  1. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome

    Atherosclerosis, Vol. 201, Núm. 1, pp. 176-183